Burghardt I - Search Results

1

Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma.

Wirsching HG, Silginer M, Ventura E, Macnair W, Burghardt I, Claassen M, Gatti S, Wichmann J, Riemer C, Schneider H, Weller M. Wirsching HG, et al. Among authors: burghardt i. Mol Ther Oncolytics. 2020 Dec 25;20:166-174. doi: 10.1016/j.omto.2020.12.009. eCollection 2021 Mar 26. Mol Ther Oncolytics. 2020. PMID: 33575479 Free PMC article.

2

Cutting Edge: ERK1 Mediates the Autocrine Positive Feedback Loop of TGF-β and Furin in Glioma-Initiating Cells.

Ventura E, Weller M, Burghardt I. Ventura E, et al. Among authors: burghardt i. J Immunol. 2017 Jun 15;198(12):4569-4574. doi: 10.4049/jimmunol.1601176. Epub 2017 May 8. J Immunol. 2017. PMID: 28484053 Free article.

3

Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.

Papa E, Weller M, Weiss T, Ventura E, Burghardt I, Szabó E. Papa E, et al. Among authors: burghardt i. Cell Death Dis. 2017 Dec 13;8(12):3210. doi: 10.1038/s41419-017-0051-2. Cell Death Dis. 2017. PMID: 29238047 Free PMC article.

4

TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells.

Ventura E, Weller M, Macnair W, Eschbach K, Beisel C, Cordazzo C, Claassen M, Zardi L, Burghardt I. Ventura E, et al. Among authors: burghardt i. J Cell Sci. 2018 Jan 9;131(1):jcs209619. doi: 10.1242/jcs.209619. J Cell Sci. 2018. PMID: 29158223 Free article.

5

Endoglin and TGF-β signaling in glioblastoma.

Burghardt I, Ventura E, Weiss T, Schroeder JJ, Seystahl K, Zielasek C, Gramatzki D, Weller M. Burghardt I, et al. Cell Tissue Res. 2021 Jun;384(3):613-624. doi: 10.1007/s00441-020-03323-5. Epub 2021 Jan 20. Cell Tissue Res. 2021. PMID: 33471197 Free PMC article.

6

A tumor-promoting role for soluble TβRIII in glioblastoma.

Burghardt I, Schroeder JJ, Weiss T, Gramatzki D, Weller M. Burghardt I, et al. Mol Cell Biochem. 2021 Aug;476(8):2963-2973. doi: 10.1007/s11010-021-04128-y. Epub 2021 Mar 26. Mol Cell Biochem. 2021. PMID: 33772427 Free PMC article.

7

Biological Role and Therapeutic Targeting of TGF-β₃ in Glioblastoma.

Seystahl K, Papachristodoulou A, Burghardt I, Schneider H, Hasenbach K, Janicot M, Roth P, Weller M. Seystahl K, et al. Among authors: burghardt i. Mol Cancer Ther. 2017 Jun;16(6):1177-1186. doi: 10.1158/1535-7163.MCT-16-0465. Epub 2017 Apr 4. Mol Cancer Ther. 2017. PMID: 28377490 Free article.

8

Prognostic Relevance of Transforming Growth Factor-β Receptor Expression and Signaling in Glioblastoma, Isocitrate Dehydrogenase-Wildtype.

Togni C, Rom E, Burghardt I, Roth P, Rushing EJ, Weller M, Gramatzki D. Togni C, et al. Among authors: burghardt i. J Neuropathol Exp Neurol. 2022 Feb 24;81(3):225-235. doi: 10.1093/jnen/nlac007. J Neuropathol Exp Neurol. 2022. PMID: 35190826

9

Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition.

Krishnan S, Szabo E, Burghardt I, Frei K, Tabatabai G, Weller M. Krishnan S, et al. Among authors: burghardt i. Oncotarget. 2015 Sep 8;6(26):22480-95. doi: 10.18632/oncotarget.4310. Oncotarget. 2015. PMID: 26090865 Free PMC article.

10

The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.

Silginer M, Burghardt I, Gramatzki D, Bunse L, Leske H, Rushing EJ, Hao N, Platten M, Weller M, Roth P. Silginer M, et al. Among authors: burghardt i. Oncogene. 2016 Jun 23;35(25):3260-71. doi: 10.1038/onc.2015.387. Epub 2015 Oct 26. Oncogene. 2016. PMID: 26500056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters